HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 31 filers reported holding HORIZON PHARMA INVT LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,839,000 | +101.5% | 1,475,000 | +20.4% | 0.00% | – |
| Q1 2020 | $1,409,000 | +4.1% | 1,225,000 | +19.5% | 0.00% | – |
| Q4 2019 | $1,354,000 | -5.0% | 1,025,000 | -16.3% | 0.00% | – |
| Q3 2019 | $1,426,000 | +43.0% | 1,225,000 | +36.1% | 0.00% | – |
| Q2 2019 | $997,000 | -2.5% | 900,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,023,000 | +14.2% | 900,000 | 0.0% | 0.00% | – |
| Q4 2018 | $896,000 | +27.3% | 900,000 | +28.6% | 0.00% | – |
| Q3 2018 | $704,000 | +47.0% | 700,000 | +40.0% | 0.00% | – |
| Q2 2018 | $479,000 | -45.0% | 500,000 | -47.4% | 0.00% | – |
| Q1 2018 | $871,000 | -18.6% | 950,000 | -17.4% | 0.00% | – |
| Q4 2017 | $1,070,000 | +3.0% | 1,150,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,039,000 | +119.2% | 1,150,000 | +109.1% | 0.00% | – |
| Q2 2017 | $474,000 | – | 550,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|